nodes	percent_of_prediction	percent_of_DWPC	metapath
Bretylium—Lightheadedness—Pentoxifylline—systemic scleroderma	0.0207	0.0207	CcSEcCtD
Bretylium—Nasal congestion—Pentoxifylline—systemic scleroderma	0.0185	0.0185	CcSEcCtD
Bretylium—Paranoia—Mycophenolate mofetil—systemic scleroderma	0.016	0.016	CcSEcCtD
Bretylium—Nasal congestion—Mometasone—systemic scleroderma	0.0159	0.0159	CcSEcCtD
Bretylium—Ventricular extrasystoles—Mycophenolic acid—systemic scleroderma	0.0153	0.0153	CcSEcCtD
Bretylium—Angina pectoris—Pentoxifylline—systemic scleroderma	0.0142	0.0142	CcSEcCtD
Bretylium—Hiccups—Mycophenolic acid—systemic scleroderma	0.0138	0.0138	CcSEcCtD
Bretylium—Ventricular extrasystoles—Lisinopril—systemic scleroderma	0.0138	0.0138	CcSEcCtD
Bretylium—Conjunctivitis—Pentoxifylline—systemic scleroderma	0.0126	0.0126	CcSEcCtD
Bretylium—Ventricular extrasystoles—Mycophenolate mofetil—systemic scleroderma	0.0121	0.0121	CcSEcCtD
Bretylium—Orthostatic hypotension—Captopril—systemic scleroderma	0.0116	0.0116	CcSEcCtD
Bretylium—Lightheadedness—Lisinopril—systemic scleroderma	0.0111	0.0111	CcSEcCtD
Bretylium—Hiccups—Mycophenolate mofetil—systemic scleroderma	0.0109	0.0109	CcSEcCtD
Bretylium—Conjunctivitis—Mometasone—systemic scleroderma	0.0109	0.0109	CcSEcCtD
Bretylium—Flushing—Pentoxifylline—systemic scleroderma	0.0108	0.0108	CcSEcCtD
Bretylium—Angina pectoris—Captopril—systemic scleroderma	0.0107	0.0107	CcSEcCtD
Bretylium—Nasal congestion—Lisinopril—systemic scleroderma	0.0099	0.0099	CcSEcCtD
Bretylium—Affect lability—Mycophenolic acid—systemic scleroderma	0.00986	0.00986	CcSEcCtD
Bretylium—Psychotic disorder—Mycophenolic acid—systemic scleroderma	0.00978	0.00978	CcSEcCtD
Bretylium—Mood swings—Mycophenolic acid—systemic scleroderma	0.00949	0.00949	CcSEcCtD
Bretylium—Orthostatic hypotension—Mycophenolic acid—systemic scleroderma	0.00915	0.00915	CcSEcCtD
Bretylium—Angina pectoris—Leflunomide—systemic scleroderma	0.00884	0.00884	CcSEcCtD
Bretylium—Sweating increased—Leflunomide—systemic scleroderma	0.00884	0.00884	CcSEcCtD
Bretylium—Hypertension—Pentoxifylline—systemic scleroderma	0.00874	0.00874	CcSEcCtD
Bretylium—Anxiety—Pentoxifylline—systemic scleroderma	0.00859	0.00859	CcSEcCtD
Bretylium—Angina pectoris—Mycophenolic acid—systemic scleroderma	0.00843	0.00843	CcSEcCtD
Bretylium—Confusional state—Pentoxifylline—systemic scleroderma	0.00833	0.00833	CcSEcCtD
Bretylium—Orthostatic hypotension—Lisinopril—systemic scleroderma	0.00824	0.00824	CcSEcCtD
Bretylium—Flushing—Captopril—systemic scleroderma	0.00818	0.00818	CcSEcCtD
Bretylium—Shock—Pentoxifylline—systemic scleroderma	0.00813	0.00813	CcSEcCtD
Bretylium—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.00799	0.00799	CcSEcCtD
Bretylium—Conjunctivitis—Leflunomide—systemic scleroderma	0.00787	0.00787	CcSEcCtD
Bretylium—Affect lability—Mycophenolate mofetil—systemic scleroderma	0.00778	0.00778	CcSEcCtD
Bretylium—Psychotic disorder—Mycophenolate mofetil—systemic scleroderma	0.00772	0.00772	CcSEcCtD
Bretylium—Sweating increased—Lisinopril—systemic scleroderma	0.0076	0.0076	CcSEcCtD
Bretylium—Angina pectoris—Lisinopril—systemic scleroderma	0.0076	0.0076	CcSEcCtD
Bretylium—Conjunctivitis—Mycophenolic acid—systemic scleroderma	0.0075	0.0075	CcSEcCtD
Bretylium—Mood swings—Mycophenolate mofetil—systemic scleroderma	0.00749	0.00749	CcSEcCtD
Bretylium—Hiccups—Prednisone—systemic scleroderma	0.00738	0.00738	CcSEcCtD
Bretylium—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00737	0.00737	CcSEcCtD
Bretylium—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.00722	0.00722	CcSEcCtD
Bretylium—Bradycardia—Mycophenolic acid—systemic scleroderma	0.00705	0.00705	CcSEcCtD
Bretylium—Syncope—Captopril—systemic scleroderma	0.00688	0.00688	CcSEcCtD
Bretylium—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00681	0.00681	CcSEcCtD
Bretylium—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00676	0.00676	CcSEcCtD
Bretylium—Loss of consciousness—Captopril—systemic scleroderma	0.00674	0.00674	CcSEcCtD
Bretylium—Angina pectoris—Mycophenolate mofetil—systemic scleroderma	0.00666	0.00666	CcSEcCtD
Bretylium—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00653	0.00653	CcSEcCtD
Bretylium—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00653	0.00653	CcSEcCtD
Bretylium—Dyspnoea—Mometasone—systemic scleroderma	0.00636	0.00636	CcSEcCtD
Bretylium—Bradycardia—Lisinopril—systemic scleroderma	0.00635	0.00635	CcSEcCtD
Bretylium—Confusional state—Captopril—systemic scleroderma	0.00631	0.00631	CcSEcCtD
Bretylium—Shock—Captopril—systemic scleroderma	0.00616	0.00616	CcSEcCtD
Bretylium—Conjunctivitis—Mycophenolate mofetil—systemic scleroderma	0.00592	0.00592	CcSEcCtD
Bretylium—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00583	0.00583	CcSEcCtD
Bretylium—Flushing—Lisinopril—systemic scleroderma	0.00579	0.00579	CcSEcCtD
Bretylium—Vertigo—Leflunomide—systemic scleroderma	0.00568	0.00568	CcSEcCtD
Bretylium—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00565	0.00565	CcSEcCtD
Bretylium—Abdominal pain—Mometasone—systemic scleroderma	0.00564	0.00564	CcSEcCtD
Bretylium—Body temperature increased—Mometasone—systemic scleroderma	0.00564	0.00564	CcSEcCtD
Bretylium—Dyspnoea—Captopril—systemic scleroderma	0.00558	0.00558	CcSEcCtD
Bretylium—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00557	0.00557	CcSEcCtD
Bretylium—Lethargy—Prednisone—systemic scleroderma	0.00547	0.00547	CcSEcCtD
Bretylium—Dizziness—Pentoxifylline—systemic scleroderma	0.00546	0.00546	CcSEcCtD
Bretylium—Hypertension—Leflunomide—systemic scleroderma	0.00546	0.00546	CcSEcCtD
Bretylium—Vertigo—Mycophenolic acid—systemic scleroderma	0.00542	0.00542	CcSEcCtD
Bretylium—Syncope—Mycophenolic acid—systemic scleroderma	0.00541	0.00541	CcSEcCtD
Bretylium—Anxiety—Leflunomide—systemic scleroderma	0.00536	0.00536	CcSEcCtD
Bretylium—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.0053	0.0053	CcSEcCtD
Bretylium—Affect lability—Prednisone—systemic scleroderma	0.00527	0.00527	CcSEcCtD
Bretylium—Vomiting—Pentoxifylline—systemic scleroderma	0.00525	0.00525	CcSEcCtD
Bretylium—Psychotic disorder—Prednisone—systemic scleroderma	0.00523	0.00523	CcSEcCtD
Bretylium—Hypertension—Mycophenolic acid—systemic scleroderma	0.00521	0.00521	CcSEcCtD
Bretylium—Feeling abnormal—Captopril—systemic scleroderma	0.00516	0.00516	CcSEcCtD
Bretylium—Gastrointestinal pain—Captopril—systemic scleroderma	0.00512	0.00512	CcSEcCtD
Bretylium—Anxiety—Mycophenolic acid—systemic scleroderma	0.00512	0.00512	CcSEcCtD
Bretylium—Mood swings—Prednisone—systemic scleroderma	0.00508	0.00508	CcSEcCtD
Bretylium—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00499	0.00499	CcSEcCtD
Bretylium—Confusional state—Mycophenolic acid—systemic scleroderma	0.00496	0.00496	CcSEcCtD
Bretylium—Abdominal pain—Captopril—systemic scleroderma	0.00495	0.00495	CcSEcCtD
Bretylium—Body temperature increased—Captopril—systemic scleroderma	0.00495	0.00495	CcSEcCtD
Bretylium—Nausea—Pentoxifylline—systemic scleroderma	0.00491	0.00491	CcSEcCtD
Bretylium—Vertigo—Lisinopril—systemic scleroderma	0.00488	0.00488	CcSEcCtD
Bretylium—Diarrhoea—Mometasone—systemic scleroderma	0.00488	0.00488	CcSEcCtD
Bretylium—Syncope—Lisinopril—systemic scleroderma	0.00487	0.00487	CcSEcCtD
Bretylium—Shock—Mycophenolic acid—systemic scleroderma	0.00484	0.00484	CcSEcCtD
Bretylium—Loss of consciousness—Lisinopril—systemic scleroderma	0.00478	0.00478	CcSEcCtD
Bretylium—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00476	0.00476	CcSEcCtD
Bretylium—Anxiety—Lisinopril—systemic scleroderma	0.00461	0.00461	CcSEcCtD
Bretylium—Dyspnoea—Leflunomide—systemic scleroderma	0.0046	0.0046	CcSEcCtD
Bretylium—Lethargy—Methotrexate—systemic scleroderma	0.00457	0.00457	CcSEcCtD
Bretylium—Vomiting—Mometasone—systemic scleroderma	0.00453	0.00453	CcSEcCtD
Bretylium—Sweating increased—Prednisone—systemic scleroderma	0.00451	0.00451	CcSEcCtD
Bretylium—Feeling abnormal—Azathioprine—systemic scleroderma	0.0045	0.0045	CcSEcCtD
Bretylium—Confusional state—Lisinopril—systemic scleroderma	0.00447	0.00447	CcSEcCtD
Bretylium—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00447	0.00447	CcSEcCtD
Bretylium—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00439	0.00439	CcSEcCtD
Bretylium—Shock—Lisinopril—systemic scleroderma	0.00436	0.00436	CcSEcCtD
Bretylium—Abdominal pain—Azathioprine—systemic scleroderma	0.00432	0.00432	CcSEcCtD
Bretylium—Body temperature increased—Azathioprine—systemic scleroderma	0.00432	0.00432	CcSEcCtD
Bretylium—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00429	0.00429	CcSEcCtD
Bretylium—Diarrhoea—Captopril—systemic scleroderma	0.00428	0.00428	CcSEcCtD
Bretylium—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00428	0.00428	CcSEcCtD
Bretylium—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00427	0.00427	CcSEcCtD
Bretylium—Feeling abnormal—Leflunomide—systemic scleroderma	0.00425	0.00425	CcSEcCtD
Bretylium—Mood swings—Methotrexate—systemic scleroderma	0.00424	0.00424	CcSEcCtD
Bretylium—Nausea—Mometasone—systemic scleroderma	0.00423	0.00423	CcSEcCtD
Bretylium—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00422	0.00422	CcSEcCtD
Bretylium—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00418	0.00418	CcSEcCtD
Bretylium—Dizziness—Captopril—systemic scleroderma	0.00414	0.00414	CcSEcCtD
Bretylium—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00411	0.00411	CcSEcCtD
Bretylium—Body temperature increased—Leflunomide—systemic scleroderma	0.00408	0.00408	CcSEcCtD
Bretylium—Abdominal pain—Leflunomide—systemic scleroderma	0.00408	0.00408	CcSEcCtD
Bretylium—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00406	0.00406	CcSEcCtD
Bretylium—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00404	0.00404	CcSEcCtD
Bretylium—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Bretylium—Vomiting—Captopril—systemic scleroderma	0.00398	0.00398	CcSEcCtD
Bretylium—Dyspnoea—Lisinopril—systemic scleroderma	0.00395	0.00395	CcSEcCtD
Bretylium—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00392	0.00392	CcSEcCtD
Bretylium—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00389	0.00389	CcSEcCtD
Bretylium—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00389	0.00389	CcSEcCtD
Bretylium—Shock—Mycophenolate mofetil—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Bretylium—Bradycardia—Prednisone—systemic scleroderma	0.00377	0.00377	CcSEcCtD
Bretylium—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00376	0.00376	CcSEcCtD
Bretylium—Diarrhoea—Azathioprine—systemic scleroderma	0.00374	0.00374	CcSEcCtD
Bretylium—Nausea—Captopril—systemic scleroderma	0.00372	0.00372	CcSEcCtD
Bretylium—Feeling abnormal—Lisinopril—systemic scleroderma	0.00365	0.00365	CcSEcCtD
Bretylium—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Bretylium—Dizziness—Azathioprine—systemic scleroderma	0.00361	0.00361	CcSEcCtD
Bretylium—Diarrhoea—Leflunomide—systemic scleroderma	0.00353	0.00353	CcSEcCtD
Bretylium—Body temperature increased—Lisinopril—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Bretylium—Abdominal pain—Lisinopril—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Bretylium—Vomiting—Azathioprine—systemic scleroderma	0.00347	0.00347	CcSEcCtD
Bretylium—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00346	0.00346	CcSEcCtD
Bretylium—Flushing—Prednisone—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Bretylium—Dizziness—Leflunomide—systemic scleroderma	0.00341	0.00341	CcSEcCtD
Bretylium—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00337	0.00337	CcSEcCtD
Bretylium—Conjunctivitis—Methotrexate—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Bretylium—Vomiting—Leflunomide—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Bretylium—Dizziness—Mycophenolic acid—systemic scleroderma	0.00326	0.00326	CcSEcCtD
Bretylium—Nausea—Azathioprine—systemic scleroderma	0.00325	0.00325	CcSEcCtD
Bretylium—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.0032	0.0032	CcSEcCtD
Bretylium—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Bretylium—Vomiting—Mycophenolic acid—systemic scleroderma	0.00313	0.00313	CcSEcCtD
Bretylium—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00307	0.00307	CcSEcCtD
Bretylium—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00307	0.00307	CcSEcCtD
Bretylium—Nausea—Leflunomide—systemic scleroderma	0.00307	0.00307	CcSEcCtD
Bretylium—Diarrhoea—Lisinopril—systemic scleroderma	0.00303	0.00303	CcSEcCtD
Bretylium—Dizziness—Lisinopril—systemic scleroderma	0.00293	0.00293	CcSEcCtD
Bretylium—Nausea—Mycophenolic acid—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Bretylium—Vertigo—Prednisone—systemic scleroderma	0.0029	0.0029	CcSEcCtD
Bretylium—Syncope—Prednisone—systemic scleroderma	0.00289	0.00289	CcSEcCtD
Bretylium—Loss of consciousness—Prednisone—systemic scleroderma	0.00284	0.00284	CcSEcCtD
Bretylium—Vomiting—Lisinopril—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Bretylium—Hypertension—Prednisone—systemic scleroderma	0.00279	0.00279	CcSEcCtD
Bretylium—Anxiety—Prednisone—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Bretylium—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Bretylium—Nausea—Lisinopril—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Bretylium—Shock—Prednisone—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Bretylium—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Bretylium—Hyperhidrosis—Prednisone—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Bretylium—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Bretylium—Vertigo—Methotrexate—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Bretylium—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Bretylium—Confusional state—Methotrexate—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Bretylium—Feeling abnormal—Prednisone—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Bretylium—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Bretylium—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Bretylium—Abdominal pain—Prednisone—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Bretylium—Body temperature increased—Prednisone—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Bretylium—Dyspnoea—Methotrexate—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Bretylium—Feeling abnormal—Methotrexate—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Bretylium—Diarrhoea—Prednisone—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Bretylium—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Bretylium—Dizziness—Prednisone—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Bretylium—Abdominal pain—Methotrexate—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Bretylium—Body temperature increased—Methotrexate—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Bretylium—Vomiting—Prednisone—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Bretylium—Nausea—Prednisone—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Bretylium—Diarrhoea—Methotrexate—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Bretylium—Dizziness—Methotrexate—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Bretylium—Vomiting—Methotrexate—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Bretylium—Nausea—Methotrexate—systemic scleroderma	0.00131	0.00131	CcSEcCtD
